Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0001209191-14-032371

Director bought 6,250 shares at $8.00 ($50,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal Director 2014-05-07 Purchase +6,250 $8.00 $50,000 6,250 D
Derivatives
Walker Neal Director 2014-05-07 Grant or award · Employee Stock Option (Right to Buy) +12,166 12,166 D
Open-market purchases · 6,250 sh · avg $8.00 · $50,000
Loading xslF345X03/doc4.xml…